HealthLeaders Media May 4, 2022
Scott Mace

Vital signs sticker aims to detect early signs of trouble, including infection, in bone marrow transplant recipients.

KEY TAKEAWAYS

Predictive analytics, portable imaging, and telemedicine round out technology utilization.

Study compensates to recognize that typical body temperature can vary from patient to patient.

Trial will start in Denver metro area, but ultimately could lead to regional remote monitoring services.

A Colorado health system is testing the feasibility of remote patient monitoring for the early detection of febrile neutropenia, a common, life-threatening complication of cancer therapy that is typically treated as an oncologic emergency.

Ten bone-marrow transplant recipients will initially participate in the trial at the University of Colorado Anschutz Medical Campus, also known as CU Anschutz. The phased approach, through...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Biotechnology, Clinical Trials, Digital Health, Health IT, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth, Trends
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
FDA Proposes the Establishment of the Center for Clinical Trial Innovation

Share This Article